发明名称 |
Ethynyl compounds |
摘要 |
The present invention relates to ethynyl derivatives of formula I;
X, G, R1, R2, R3, R3′, R4, R4′, R5, R6, R6′, m, and n are as defined herein or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. Compounds of formula I are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5). They can be used for the treatment of schizophrenia or cognitive disorders. |
申请公布号 |
US8957213(B2) |
申请公布日期 |
2015.02.17 |
申请号 |
US201213452973 |
申请日期 |
2012.04.23 |
申请人 |
Hoffman-La Roche Inc. |
发明人 |
Jaeschke Georg;Jolidon Synese;Lindemann Lothar;Stadler Heinz;Vieira Eric |
分类号 |
C07D401/04;C07D401/14;A61K31/4439;A61K31/444;C07D403/04 |
主分类号 |
C07D401/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of formula: wherein X is C—R, wherein R is hydrogen or halogen; G is CH; R1 is phenyl or pyridinyl, each of which is optionally substituted by halogen; R2 is hydrogen, lower alkyl, hydroxy, lower alkoxy or C(O)O-benzyl; R3, R3′, R4, R4′, R6, and R6′ are each independently hydrogen or lower alkyl;
or R6 and R4 together with the carbon atom to which they are attached form a C4-6-cycloalkyl ring, when m is 0 and n is 1 or 2; R5 is hydrogen or lower alkyl; n is 0 or 1; and m is 0 or 1; with the proviso that n is 0 when m is 1 and n is 1 when m is 0; or a pharmaceutically acceptable acid addition salt thereof. |
地址 |
Nutley NJ US |